Delivery Order SPE2DB22D2006-SPE2DB23FW1AX
Award Date 7/11/23
Potential Completion Date 7/12/23
Potential Value $3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $14,162 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561948200 REMICADE 100 MG VIALS. REMICADE is a biologic medication used to treat certain autoimmune diseases. The place of performance for the delivery order is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is August 25-28, 2023. No major subcontractors or set aside designations were identified. The delivery order was issued against...
- The Defense Logistics Agency awarded a $11,774.40 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562052286 REMICADE 100 MG VIALS. The place of performance is Conshohocken, Pennsylvania. The period of performance is September 5, 2023 through September 6, 2023. This delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products in support of the Department of Defense's medical readiness programs. No...
- The Defense Logistics Agency awarded a $36,459 delivery order to Amerisourcebergen Drug Corporation for 4561806089 REMICADE 100 MG VIALS. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and calls for delivery of the specified pharmaceutical products to a facility in Conshohocken, Pennsylvania by August 15, 2023 to support DLA programs. No set aside designation or subcontractors were identified. REMICADE is an immunosuppressive drug used to treat...
- The U.S. Defense Logistics Agency (DLA) awarded a $34,436.74 Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp for the supply of 4565677215 REMICADE 100 MG VIALS. This contract, which does not have a set-aside designation, has a period of performance through September 5, 2024. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this award. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a $15,209 delivery order to Amerisourcebergen Drug Corporation for 100 mg vials of the drug Remicade. The firm fixed price order is for performance from August 31, 2023 through September 1, 2023 at Amerisourcebergen's facility in Conshohocken, Pennsylvania. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for the rheumatoid arthritis treatment Remicade supports the Agency's mission to provide essential...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $6,250.50 firm fixed price delivery order contract to supply 4561696173 units of Remicade 100 mg vials. The single day contract has a period of performance from August 3 to August 4, 2023, with all work taking place in Conshohocken, Pennsylvania. As the Defense Logistics Agency is responsible for procuring pharmaceuticals and medical supplies for the U.S. Department of Defense, this delivery order was likely placed to...
- The Defense Logistics Agency awarded a delivery order valued at $3,032.89 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials. The contract, awarded September 2, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $7,774.78 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999.00 ceiling through December 2026. The delivery order was executed on August 4, 2025, with an ultimate completion date of August 5,...
- The Defense Logistics Agency awarded a $45,057 delivery order to Amerisourcebergen Drug Corporation for 4561478527 units of Remicade 100 mg vials. The firm fixed price order is being fulfilled from the contractor's Conshohocken, Pennsylvania location to support Defense Logistics Agency programs. No subcontractors or set aside designations were identified. Remicade is a biologic drug used to treat certain autoimmune disorders. This award draws upon the prime contractor's experience supplying...
- The Defense Logistics Agency awarded a delivery order valued at $32,265.28 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials. The contract is classified as a firm fixed price delivery order with an ultimate completion date of April 24, 2025, and was competitively awarded without set-aside provisions. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB23FW1AXDelivery Order
The Defense Logistics Agency awarded a $3,007.54 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561466347 REMICADE 100 MG VIALS. The place of performance is Conshohocken, Pennsylvania. The period of performance is July 11, 2023 through July 12, 2023. REMICADE is a biologic drug used to treat certain autoimmune diseases. This delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to support the DLA's medical supply needs. No set aside designation or subcontractors were identified.
Generated 12/23/23, 1:56 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 7/11/23 |